A federal advisory committee is reviewing the routine administration of hepatitis B vaccines to newborns, raising questions about current policies. Senator Pennacchio has voiced concerns regarding the broad mandate for vaccinating children against hepatitis B, particularly when New Jersey already requires expectant mothers to be tested for the virus.
Martin Kulldorff, a former professor at Harvard Medical School, stated, “Unless the mother is hepatitis b positive, an argument can be made for a delay of the vaccine for this infection, which is primarily spread by sexual activity and intravenous drug use.”
According to a recent KFF Health News article, most individuals with chronic hepatitis B are from outside the United States and are Asian or Pacific Islanders.
Senator Pennacchio noted that in New Jersey, not only are pregnant women tested for hepatitis B, but medical staff involved in childbirth must also be vaccinated and periodically checked for antibody levels. He questioned why a universal vaccine mandate exists under these circumstances. “Unless there is a person close to the child who is infected, or unless the child is in an environment where drugs are used this broad mandated application should not exist!” said Sen. Pennacchio.
Pennacchio, who previously worked as a dentist, shared his experience with vaccination requirements: he and his staff were required both to receive the hepatitis B vaccine and to undergo periodic blood tests to ensure adequate antibody levels. “That was the established medical protocol,” said Sen. Pennacchio.
The senator raised concerns about policies that require three doses of the vaccine before school entry—including one at birth—but do not call for further follow-up over the next 17 years. He asked why children are subject to different standards than adults and how those standards were determined.
Senator Pennacchio advocates for parents and doctors to decide on administering the hepatitis B vaccine based on individual risk assessment. He stated that determining the “risk-reward” benefit should occur during discussions between families and healthcare providers.
Currently, Senator Pennacchio is drafting legislation aimed at removing political influence from decisions about vaccine administration schedules and focusing instead on medical science and protocols.
